Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benhur Lee

Showing results (91-100 of 211) with videos related to

Pageof 22
Sort By:
Biophysical Journal|February 12, 2022
Single-virus assay reveals membrane determinants and mechanistic features of Sendai virus bindingAmy Lam, Orville O Kirkland, Papa Freduah Anderson, et al.
Journal of Virology|December 16, 2014
Timing of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cellsOmai B Garner, Tatyana Yun, Olivier Pernet, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
SARS-CoV-2 Nsp15 antagonizes the cGAS-STING-mediated antiviral innate immune responsesHsin-Ping Chiu, Yao Yu Yeo, Tsoi Ying Lai, et al.
The Journal of General Virology|March 25, 2026
SARS-CoV-2 Nsp15 facilitates immune evasion and viral replication by limiting multiple host innate immune pathways, including cGAS-STINGHsin-Ping Chiu, Yao Yu Yeo, Tsoi Ying Lai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokinesErnest L Levroney, Hector C Aguilar, Jennifer A Fulcher, et al.
Journal of Virology|August 21, 2009
A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strainsSamantha H Johnston, Michael A Lobritz, Sandra Nguyen, et al.
Retrovirology|November 8, 2011
HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entryMichael Roche, Martin R Jakobsen, Anne Ellett, et al.
Glycobiology|August 17, 2017
Galectin-9 binds to O-glycans on protein disulfide isomeraseKatrin Schaefer, Nicholas E Webb, Mabel Pang, et al.
Retrovirology|November 5, 2016
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maravirocKatharina Borm, Martin R Jakobsen, Kieran Cashin, et al.
The Journal of General Virology|November 1, 2017
ICTV Virus Taxonomy Profile: PneumoviridaeBert Rima, Peter Collins, Andrew Easton, et al.
Pageof 22

Showing results (91-100 of 211) with videos related to

Sort By:
Pageof 22
Biophysical Journal|February 12, 2022
Single-virus assay reveals membrane determinants and mechanistic features of Sendai virus bindingAmy Lam, Orville O Kirkland, Papa Freduah Anderson, et al.
Journal of Virology|December 16, 2014
Timing of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cellsOmai B Garner, Tatyana Yun, Olivier Pernet, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
SARS-CoV-2 Nsp15 antagonizes the cGAS-STING-mediated antiviral innate immune responsesHsin-Ping Chiu, Yao Yu Yeo, Tsoi Ying Lai, et al.
The Journal of General Virology|March 25, 2026
SARS-CoV-2 Nsp15 facilitates immune evasion and viral replication by limiting multiple host innate immune pathways, including cGAS-STINGHsin-Ping Chiu, Yao Yu Yeo, Tsoi Ying Lai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokinesErnest L Levroney, Hector C Aguilar, Jennifer A Fulcher, et al.
Journal of Virology|August 21, 2009
A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strainsSamantha H Johnston, Michael A Lobritz, Sandra Nguyen, et al.
Retrovirology|November 8, 2011
HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entryMichael Roche, Martin R Jakobsen, Anne Ellett, et al.
Glycobiology|August 17, 2017
Galectin-9 binds to O-glycans on protein disulfide isomeraseKatrin Schaefer, Nicholas E Webb, Mabel Pang, et al.
Retrovirology|November 5, 2016
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maravirocKatharina Borm, Martin R Jakobsen, Kieran Cashin, et al.
The Journal of General Virology|November 1, 2017
ICTV Virus Taxonomy Profile: PneumoviridaeBert Rima, Peter Collins, Andrew Easton, et al.
Pageof 22